The FTC is seeking public comment on Cardinal Health's application to sell its former nuclear pharmacy assets to Patient Care Infusion. Cardinal is required to sell these assets--located in Las Vegas, Albuquerque, and El Paso--under the 2011 settlement with the FTC for its acquisition of three nuclear pharmacies from Biotech.
Public comments on the sale will be accepted until March 26, 2012.
Source: FTC Press Release
Related Content: Reviving Competition in Healthcare Markets: The Use of Section 5 of the FTC Act (David Balto)